- Home
- ALVO vs OGN Comparison
ALVO vs OGN Comparison
Compare ALVO & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- OGN
- Stock Information
- Founded
- ALVO 2013
- OGN 1923
- Country
- ALVO Luxembourg
- OGN United States
- Employees
- ALVO N/A
- OGN N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- ALVO Health Care
- OGN Health Care
- Exchange
- ALVO Nasdaq
- OGN Nasdaq
- Market Cap
- ALVO 2.5B
- OGN N/A
- IPO Year
- ALVO N/A
- OGN N/A
- Fundamental
- Price
- ALVO $9.38
- OGN $9.02
- Analyst Decision
- ALVO Buy
- OGN Hold
- Analyst Count
- ALVO 1
- OGN 4
- Target Price
- ALVO $18.00
- OGN $18.50
- AVG Volume (30 Days)
- ALVO 140.4K
- OGN 7.6M
- Earning Date
- ALVO 05-07-2025
- OGN 05-01-2025
- Dividend Yield
- ALVO N/A
- OGN 9.53%
- EPS Growth
- ALVO N/A
- OGN N/A
- EPS
- ALVO 0.34
- OGN 2.88
- Revenue
- ALVO $587,890,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- ALVO $33.92
- OGN N/A
- Revenue Next Year
- ALVO $45.74
- OGN $0.91
- P/E Ratio
- ALVO $27.67
- OGN $3.13
- Revenue Growth
- ALVO 413.92
- OGN N/A
- 52 Week Low
- ALVO $7.35
- OGN $8.05
- 52 Week High
- ALVO $14.65
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- ALVO 58.67
- OGN 33.62
- Support Level
- ALVO $7.90
- OGN $8.05
- Resistance Level
- ALVO $8.50
- OGN $13.25
- Average True Range (ATR)
- ALVO 0.39
- OGN 0.71
- MACD
- ALVO 0.18
- OGN -0.21
- Stochastic Oscillator
- ALVO 67.72
- OGN 18.67
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.